Literature DB >> 27439445

Short-term remote ischemic preconditioning is not associated with improved blood pressure and exercise capacity in young adults.

Laura Banks1, Greg D Wells2,3, Nadia A Clarizia1, Emilie Jean-St-Michel1, Adam L McKillop1, Andrew N Redington1,4, Brian W McCrindle1,4.   

Abstract

We sought to determine whether a 9-day remote ischemic preconditioning (IPC) causes improvements in exercise performance, energetics, and blood pressure. Ten participants (mean age 24 ± 4 years) had no changes in aerobic capacity (preintervention: 38 ± 10 mL/(kg·min)(-1) vs. postintervention: 38 ± 10 mL/(kg·min)(-1)), blood pressure (preintervention: 112 ± 7/66 ± 6 mm Hg vs. postintervention: 112 ± 10/62 ± 5 mm Hg), cardiac phosphocreatinine-to-adenosine-triphosphate ratio (preintervention: 2.1 ± 0.5 vs. postintervention: 2.3 ± 0.4), and postexercise skeletal muscle phosphocreatine recovery (preintervention: 34 ± 11 s vs. postintervention: 31 ± 11 s). Short-term remote IPC may be ineffective in improving these outcomes.

Entities:  

Keywords:  cardiac energy metabolism; consommation d’oxygène de pointe; ischemia–reperfusion; ischémie-reperfusion; magnetic resonance spectroscopy; métabolisme énergétique cardiaque; peak oxygen consumption; phosphocreatine recovery; phosphocréatine de récupération; spectroscopie par résonance magnétique

Mesh:

Substances:

Year:  2016        PMID: 27439445     DOI: 10.1139/apnm-2016-0024

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  9 in total

1.  Ischemic preconditioning and exercise performance: shedding light through smallest worthwhile change.

Authors:  Moacir Marocolo; Mario A Moura Simim; Anderson Bernardino; Iury Reis Monteiro; Stephen D Patterson; Gustavo R da Mota
Journal:  Eur J Appl Physiol       Date:  2019-08-26       Impact factor: 3.078

2.  Impact of 8 weeks of repeated ischemic preconditioning on running performance.

Authors:  Joshua T Slysz; Jamie F Burr
Journal:  Eur J Appl Physiol       Date:  2019-04-05       Impact factor: 3.078

Review 3.  The effect of remote ischaemic conditioning on blood pressure response: A systematic review and meta-analysis.

Authors:  Biggie Baffour-Awuah; Gudrun Dieberg; Melissa J Pearson; Neil A Smart
Journal:  Int J Cardiol Hypertens       Date:  2021-02-23

4.  Lack of a Dose Response from 7 Days of Ischemic Preconditioning in Moderately trained Cyclists.

Authors:  Angus Lindsay; Carl Petersen; Hamish Ferguson; Gavin Blackwell; Stephen Rickerby
Journal:  Sports Med Int Open       Date:  2018-09-07

5.  Ischemic Preconditioning Enhances Aerobic Adaptations to Sprint-Interval Training in Athletes Without Altering Systemic Hypoxic Signaling and Immune Function.

Authors:  Pénélope Paradis-Deschênes; Denis R Joanisse; Pascale Mauriège; François Billaut
Journal:  Front Sports Act Living       Date:  2020-04-28

Review 6.  Chronic Limb Remote Ischemic Conditioning may have an Antihypertensive Effect in Patients with Hypertension.

Authors:  Wenting Guo; Changhong Ren; Bowei Zhang; Wenbo Zhao; Yu Gao; Wantong Yu; Xunming Ji
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

7.  The effect of 1 week of repeated ischaemic leg preconditioning on simulated Keirin cycling performance: a randomised trial.

Authors:  Angus Lindsay; Carl Petersen; Gavin Blackwell; Hamish Ferguson; Greg Parker; Nina Steyn; Steven P Gieseg
Journal:  BMJ Open Sport Exerc Med       Date:  2017-05-31

8.  The efficacy of 'static' training interventions for improving indices of cardiorespiratory fitness in premenopausal females.

Authors:  P J J Herrod; J E M Blackwell; B F Moss; A Gates; P J Atherton; J N Lund; J P Williams; B E Phillips
Journal:  Eur J Appl Physiol       Date:  2018-12-27       Impact factor: 3.078

9.  Remote Ischemic Preconditioning Has No Short Term Effect on Blood Pressure, Heart Rate, and Arterial Stiffness in Healthy Young Adults.

Authors:  Jan Müller; Marius Taebling; Renate Oberhoffer
Journal:  Front Physiol       Date:  2019-08-21       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.